Alimera Sciences Claimed Company
Alimera Sciences is a biopharmaceutical company thatĀ researches, develops and commercializesĀ prescription ophthalmic pharmaceuticals. read more
HR or Marketing? Claim Your Free Employer Account
Kenneth Green Ph.D. ā Chief Scientific Officer, Global Head of Research & Development and Senior Vice President at Alimera Sciences
Executive Bio
Dr. Kenneth Green, also known as Ken, Ph.D., has been Chief Scientific Officer of Alimera Sciences Limited since 2007. Dr. Green has been the Chief Scientific Officer and Senior Vice President at Alimera Sciences, Inc. since January 2007 and serves as its Global Head of Research and Development. Dr. Green served as Vice President of Scientific Affairs of Alimera Sciences Inc. since joining in 2004 until January 2007. Dr. Green is responsible for all preclinical and clinical development activities supporting the companies portfolio. He provides input to the project teams regarding clinical and preclinical trial design and development strategy and supports the marketing and sales organizations with input to post-marketing study strategies. Additionally, he serves as a Member of the Executive Committee helping to define the overall strategic direction of it. Prior to Alimera Sciences, Dr. Green worked with Lederle Laboratories, Storz Ophthalmics, Bausch & Lomb, CIBA Vision and Novartis Ophthalmics. At Novartis Ophthalmics, he served as the Global Head of Clinical Science, where he was involved with the development of Visudyne, Rescula and Zaditor in both the US and Europe. Dr. Green's ophthalmology experience spans 20 years and includes clinical development experience in the areas of allergy, infection, glaucoma, age-related macular degeneration, diabetic retinopathy and myopia. In 2003, he presented to FDA advisory panel convened to define a clinical endpoint for the pharmacological treatment of myopia. He started his career in the pharmaceutical industry in 1984, as a basic research scientist in drug discovery at Lederle Laboratories and has since held positions in many areas of drug development. He has published several papers and is listed as an inventor on several U.S. patents. Dr. Green earned his B.A. degree in chemistry from Southern Illinois University and a Ph.D. in organic chemistry from Ohio State University.
Key Executives
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Chief Scientific Officer, Global Head of Research & Development and Senior Vice President
$417k
$818k
Executive Team Culture Ratings from Alimera Sciences Employees
BOTTOM
20%
Alimera Sciences' Executive Team scores in the Bottom 20%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Alimera SciencesNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Alimera SciencesAlimera Sciences' Executive Team at a Glance
Based on 3 ratings, Alimera Sciences' employees are less satisfied with their Executive Team and give them a āDā or 56/100.
Alimera Sciences' Executive Team ranks in the Bottom 25% of other companies in Atlanta and Bottom 20% of other companies on Comparably that also have 51-200 Employees.
×